...
首页> 外文期刊>Experimental Cell Research >Circular RNA-hsa-circ-0000670 promotes gastric cancer progression through the microRNA-384/SIX4 axis
【24h】

Circular RNA-hsa-circ-0000670 promotes gastric cancer progression through the microRNA-384/SIX4 axis

机译:环状rna - hsa -中国保监会0000670促进胃通过微- 384 / SIX4癌症恶化轴

获取原文
获取原文并翻译 | 示例
           

摘要

Circular RNAs (circRNAs), a special type of non-coding RNA molecules, have been addressed to be implicated in gastric cancer progression. The GSE93541 and GSE83521 microarrays found hsa-circRNA-000670 (hsa-circ-0000670) as an up-regulated circRNAin gastric cancer. We mainly investigated the function and molecular mechanisms of hsa-circ-0000670 involved in gastric cancer. The expression of hsa-circ-0000670 was determined by RT-qPCR to be highly expressed in gastric cancer tissues relative to corresponding adjacent normal tissues, as well as in gastric cancer cell lines relative to normal gastric mucosal epithelial cell line. By conducting EdU, scratch test and Transwell assays, hsa-circ-000670 was found to be a tumor promoter by potentiating the proliferative, invasive and migrating capabilities of gastric cancer cells. Consistently, a tumor-promotive role of hsa-circ-000670 was validated in vivo. Dual-luciferase reporter gene and RIP assays identified the binding of hsa-circ-0000670 to microRNA-384 (miR-384) and the binding of miR-384 to sine oculis-related homeobox 4 (SIX4). The oncogenic potential of hsa-circ-0000670 in gastric cancer cells were inhibited by overexpressed miR-384. Mechanistically, SIX4 was targeted by miR-384 and was upregulated in gastric cancer. High SIX4 expression was suggested to correlate with the poor prognosis of gastric cancer patients. Additionally, silencing of SIX4 delayed tumor growth and progression, which were reversed by overexpression of hsa-circ-0000670. Taken together, hsa-circ-0000670 acts as a tumor promotor in gastric cancer progression and might be a potential target for gastric cancer treatment.
机译:圆形的rna (circRNAs),一种特殊类型的非编码RNA分子,已经解决与胃癌的进展。GSE93541和GSE83521微阵列hsa - circrna - 000670 (hsa -中国保监会0000670)作为一个差异circRNAin胃癌。研究函数和分子hsa -中国保监会0000670参与机制胃癌。hsa -中国保监会0000670由RT-qPCR决定胃癌组织中高度表达相对于对应的相邻正常组织,以及在胃癌细胞株相对于正常胃粘膜上皮细胞系。Transwell化验,hsa -中国保监会000670被发现肿瘤促进剂的增效增殖、侵袭性和迁移胃癌细胞的功能。一直,一个tumor-promotive作用hsa -中国保监会000670年体内进行验证。Dual-luciferase报告基因和RIP化验确认绑定hsa -中国保监会0000670微rna - 384 (mir - 384)和mir - 384的绑定对正弦oculis-related同源框4 (SIX4)。致癌的潜在hsa -中国保监会0000670胃癌细胞被抑制中mir - 384。mir - 384,调节的目标胃癌。建议与不良预后有关胃癌患者。SIX4推迟肿瘤的生长和发展,逆转的超表达的hsa -中国保监会0000670。hsa -中国保监会0000670作为肿瘤催化剂胃癌进展,可能是一个潜在的胃癌治疗的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号